15
Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far).

Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

Embed Size (px)

Citation preview

Page 1: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

Alastair Hay, Consultant Senior Lecturer in Primary Health Care

The TARGET Programme: strengths, weaknesses, opportunities and lessons

learned (so far).

Page 2: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

What is the problem?• High rates of RTIs in children lead to

• Economic burden to health services and parents (and their employers)

• Unnecessary use of antibiotics leads toIncreased selective pressure on antimicrobial

resistance andMedicalisation of illness vicious or virtuous circle

• Clinical uncertainty drives use but leads to low specificity

2

Page 3: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

What does the TARGET team believe is the solution?

• Clinical prediction rule?• Yes, but…

What to “predict” (diagnosis vs. prognosis)? Which symptoms and signs to measure? How would a prediction rule fit into current clinical

practice (simple vs. complex intervention)?

3

Page 4: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

Programme overview4

Parent Clinician Child

WS2* - Qualitative studies

Parent knowledge, health seeking behaviour

and information needs

WS1* - Systematic reviews

a) Factors associated with frequent attendance b) Natural history of RTI symptoms in childhood;

WS3* - Prospective cohort study

Clinical (and microbiological) factors associated with poor

prognosis to derive and validate a clinical rule to

predict hospitalisation from RTI

WS4* - cluster randomised controlled

trial Clinical and cost effectiveness of clinical

rule + parent information

Years 1

2

3

4

5

Page 5: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

Programme overview5

Parent Clinician Child

WS2* - Qualitative studies

Parent knowledge, health seeking behaviour

and information needs

WS1* - Systematic reviews

a) Factors associated with frequent attendance b) Natural history of RTI symptoms in childhood;

WS3* - Prospective cohort study

Clinical (and microbiological) factors associated with poor

prognosis to derive and validate a clinical rule to

predict hospitalisation from RTI

WS4* - cluster randomised controlled

trial Clinical and cost effectiveness of clinical

rule + parent information

Years 1

2

3

4

5

Page 6: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Research questions • Can baseline characteristics be used to

predict the need for hospitalisation in children <12 years presenting to primary care with acute cough?

• Do specific bacteria and/or viral microbes (or combinations of microbes) predict poor prognosis?

6

Page 7: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Design: prospective cohort (derivation and validation) study

• Eligibility: Children <12 years presenting to primary care with acute cough

• Independent variables• Baseline symptoms and signs + other

characteristics (e.g. deprivation)• Detailed microbiology and virology

7

Page 8: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Dependent variables• Primary – hospitalisation• Secondary - symptom duration, symptom

severity, antibiotic prescribing and reconsultations

8

Page 9: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Challenges• How to determine sample size• Logistics of recruiting a large cohort• Minimising (and/or adjusting for) spectrum

bias• Confounding by indication

9

Page 10: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Sample size methods1. Certainty with which strength of association

between individual predictors and outcome

2. Overall precision of the sensitivity and specificity of a validated rule

3. Ratio of candidate predictors to outcome events

10

Page 11: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Recruitment logistics• Collaboration• Simple data collection proforma• Web and paper based• Re-imbursement for clinician time

11

Page 12: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

12

DESCARTE pooled recruitment up to end of May 2009(Consent Form Data)

0

2000

4000

6000

8000

10000

12000

14000

16000

18000

Jan

-07

Fe

b-0

7M

ar-

07

Ap

r-0

7M

ay-

07

Jun

-07

Jul-

07

Au

g-0

7S

ep

-07

Oct

-07

No

v-0

7D

ec-

07

Jan

-08

Fe

b-0

8M

ar-

08

Ap

r-0

8M

ay-

08

Jun

-08

Jul-

08

Au

g-0

8S

ep

-08

Oct

-08

No

v-0

8D

ec-

08

Jan

-09

Fe

b-0

9M

ar-

09

Ap

r-0

9M

ay-

09

Months of study

Nu

mb

er o

f p

atie

nts

Actual cumulative recruitment

Page 13: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Spectrum bias• Difference in illness (e.g. aetiology) between

derivation and validation datasets• Can undermine validation• One potential solution is to anticipate which

parameters are most likely to change and• Measure them (e.g. microbiology)• Adjust analysis for them

13

Page 14: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

WS3 – CPR study

• Confounding by indication• Can potentially be reduced by

Derive and validate in the control arm of a RCT (unlikely to be ethical)

Assume that antibiotic prescribing is not associated with risk of outcome and exclude children prescribed antibiotics

Include all children, look for association between antibiotics and key predictors and model antibiotic effects

14

Page 15: Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far)

15

Summary

• Albeit with some limitations, CPRs can be appropriately applied in the infection field. Limitations include• Spectrum bias• Confounding by indication (antibiotic use)

• Logistic challenges of recruiting large sample sizes• Collaboration• Use of technology to help manage data

• Funders want to support CPR research